Fey G - Search Results

1

Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia.

O'Hear C, Heiber JF, Schubert I, Fey G, Geiger TL. O'Hear C, et al. Among authors: fey g. Haematologica. 2015 Mar;100(3):336-44. doi: 10.3324/haematol.2014.112748. Epub 2014 Dec 5. Haematologica. 2015. PMID: 25480499 Free PMC article.

2

A recombinant trispecific single-chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targeting.

Kügler M, Stein C, Kellner C, Mentz K, Saul D, Schwenkert M, Schubert I, Singer H, Oduncu F, Stockmeyer B, Mackensen A, Fey GH. Kügler M, et al. Br J Haematol. 2010 Sep;150(5):574-86. doi: 10.1111/j.1365-2141.2010.08300.x. Epub 2010 Jul 16. Br J Haematol. 2010. PMID: 20636437 Free article.

3

A single-chain triplebody with specificity for CD19 and CD33 mediates effective lysis of mixed lineage leukemia cells by dual targeting.

Schubert I, Kellner C, Stein C, Kügler M, Schwenkert M, Saul D, Mentz K, Singer H, Stockmeyer B, Hillen W, Mackensen A, Fey GH. Schubert I, et al. MAbs. 2011 Jan-Feb;3(1):21-30. doi: 10.4161/mabs.3.1.14057. Epub 2011 Jan 1. MAbs. 2011. PMID: 21081841 Free PMC article.

4

A recombinant triplebody with specificity for CD19 and HLA-DR mediates preferential binding to antigen double-positive cells by dual-targeting.

Schubert I, Kellner C, Stein C, Kügler M, Schwenkert M, Saul D, Stockmeyer B, Berens C, Oduncu FS, Mackensen A, Fey GH. Schubert I, et al. MAbs. 2012 Jan-Feb;4(1):45-56. doi: 10.4161/mabs.4.1.18498. MAbs. 2012. PMID: 22327429 Free PMC article.

5

NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2.

Braciak TA, Wildenhain S, Roskopf CC, Schubert IA, Fey GH, Jacob U, Hopfner KP, Oduncu FS. Braciak TA, et al. J Transl Med. 2013 Nov 16;11:289. doi: 10.1186/1479-5876-11-289. J Transl Med. 2013. PMID: 24237598 Free PMC article.

6

T cell-recruiting triplebody 19-3-19 mediates serial lysis of malignant B-lymphoid cells by a single T cell.

Roskopf CC, Schiller CB, Braciak TA, Kobold S, Schubert IA, Fey GH, Hopfner KP, Oduncu FS. Roskopf CC, et al. Oncotarget. 2014 Aug 15;5(15):6466-83. doi: 10.18632/oncotarget.2238. Oncotarget. 2014. PMID: 25115385 Free PMC article.

7

CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells.

Schiller CB, Braciak TA, Fenn NC, Seidel UJ, Roskopf CC, Wildenhain S, Honegger A, Schubert IA, Schele A, Lämmermann K, Fey GH, Jacob U, Lang P, Hopfner KP, Oduncu FS. Schiller CB, et al. Among authors: fey gh. Oncotarget. 2016 Dec 13;7(50):83392-83408. doi: 10.18632/oncotarget.13110. Oncotarget. 2016. PMID: 27825135 Free PMC article.

8

Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells.

Braciak TA, Roskopf CC, Wildenhain S, Fenn NC, Schiller CB, Schubert IA, Jacob U, Honegger A, Krupka C, Subklewe M, Spiekermann K, Hopfner KP, Fey GH, Aigner M, Krause S, Mackensen A, Oduncu FS. Braciak TA, et al. Among authors: fey gh. Oncoimmunology. 2018 Jul 30;7(9):e1472195. doi: 10.1080/2162402X.2018.1472195. eCollection 2018. Oncoimmunology. 2018. PMID: 30228941 Free PMC article.

9

A dual-targeting triplebody mediates preferential redirected lysis of antigen double-positive over single-positive leukemic cells.

Schubert I, Saul D, Nowecki S, Mackensen A, Fey GH, Oduncu FS. Schubert I, et al. MAbs. 2014 Jan-Feb;6(1):286-96. doi: 10.4161/mabs.26768. MAbs. 2014. PMID: 24135631 Free PMC article. Clinical Trial.

10

Effective elimination of acute myeloid leukemic cells by recombinant bispecific antibody derivatives directed against CD33 and CD16.

Singer H, Kellner C, Lanig H, Aigner M, Stockmeyer B, Oduncu F, Schwemmlein M, Stein C, Mentz K, Mackensen A, Fey GH. Singer H, et al. J Immunother. 2010 Jul-Aug;33(6):599-608. doi: 10.1097/CJI.0b013e3181dda225. J Immunother. 2010. PMID: 20551837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters